There were 200 delegates attending, representing a diverse range of organisations, many Drug companies & 5 patient Representatives
It was interesting to learn how decisions are made on which drugs will be made available & which are regected & why.It was stressed how important it was to present a well structured & thought out case when applying for acceptance of new drugs.
2 very relevant sessions were "How to make a good economic submission to SMC", &"How to make a good patient interest group submission to SMC"
There was much information to absorb, & a shortened lunch break left little time for networking, but I managed to talk to several delegates about MCF, they were not aware we exsisted

Details of the conference & work of the SMC will be on their website in due course, for anyone interested. Fran.